2016 Update on SMA-FDA Interactions
The SMA drug pipeline has grown dramatically in just over a decade. Of the 18 programs in the pipeline, six of these are in clinical trials, and several of those are in Phase 2 and Phase 3 clinical trials. Reaching and achieving FDA approval is a major step in our path to a treatment and […]
2016 Update on SMA-FDA Interactions Read More »